Loading stock data…
Research Solutions (RSSS)
$2.29
After Hours$2.27-0.02 (-0.87%)· Last close Jun 29
Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Research Solutions, Inc. in the Technology sector is trading at $2.29 with a market capitalization of $77M. Wall Street consensus targets $3.83 (3 analysts), implying a +67.4% move over the next 12 months. The stock is currently near its 52-week low of $2.00, remaining 17.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +67.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $12.12M↑ | $11.79M↓ | $12.31M↓ | $12.44M↓ | $12.66M |
| Gross Profit | $6.27M↑ | $6.18M↓ | $6.23M↓ | $6.34M↑ | $6.27M |
| Operating Income | $1.06M↑ | $775,462↓ | $944,415↓ | $1.12M↑ | $512,403 |
| Net Income | $860,206↑ | $546,919↓ | $749,387↓ | $2.36M↑ | $216,470 |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internation...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$76.59M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
23.70%
Volume
Today's trading volume
38,990
Recent News
Research Solutions (RSSS) Stock Sees Fair Value Cut As Analysts Flag Revenue And Churn
The average analyst fair value estimate for Research Solutions has been reset from US$5.33 to US$3.83 per share, a reduction of roughly 28% that reflects a cooler view on the stock. Analysts link this lower price target to mixed quarterly results, softer revenue trends, and churn concerns, even as they acknowledge solid execution on costs and customer wins. As you read on, you will see how these shifting assumptions are shaping the evolving analyst narrative and which signals to watch...
Long Cast Advisors’ Views in Research Solutions’ (RSSS) Insights on Business Resilience and Innovation
Long Cast Advisors, an independent registered investment adviser, released its Q1 2026 investor letter. A copy of the letter is available to download here. For 1Q26, the portfolio’s cumulative net returns were flat, aligning with small and micro-cap market indexes, including the Russell 2000 and iShares ETFs. Geopolitical and economic factors, including the Iran war, […]
Research Solutions Q3 Earnings Call Highlights
Research Solutions (NASDAQ:RSSS) reported improved profitability in its fiscal 2026 third quarter, even as revenue declined from a year earlier and management said business-to-business churn remained a drag on growth. The company, which provides cloud-based research workflow tools including Article
Research Solutions Inc. (RSSS) Matches Q3 Earnings Estimates
Research Solutions (RSSS) delivered earnings and revenue surprises of 0.00% and -2.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Kornit Digital (KRNT) Reports Q1 Loss, Tops Revenue Estimates
Kornit Digital (KRNT) delivered earnings and revenue surprises of 0.00% and +3.96%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?